Effects of demineralized freeze-dried bone allograft on gene expression of osteoblastlike MG63 cells

International Journal of Periodontics and Restorative Dentistry

Volumn 27, Issue 6, 2007, Pages 596-601

  Carinci, Francesco ^a   Piattelli, Adriano ^b,e   Degidi, Marco ^c   Palmieri, Annalisa ^c,d   Perrotti, Vittoria ^d   Scapoli, Luca ^c,d   Martinelli, Marcella ^a   Zuccarino, Luca ^a   Pezzetti, Furio ^c,d  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d CARISBO Foundation   (Italy)

^e University of Ferrara ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE REGENERATION; BONE TRANSPLANTATION; CELL CULTURE; DNA MICROARRAY; FREEZE DRYING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HISTOLOGY; HUMAN; METABOLISM; OSTEOBLAST; PHYSIOLOGY;

BONE REGENERATION; BONE TRANSPLANTATION; CELLS, CULTURED; DECALCIFICATION TECHNIQUE; FREEZE DRYING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS;

EID: 36949036920     PISSN: 01987569     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Herold RW, Pashley DH, Cuenin MF, et al. The effects of varying degrees of allograft decalcification of cultured porcine osteoclasts cells. J Periodontol 2002;73:213-219.
2. Paul BF, Horning GM, Hellstein JW, Schafer DR. The osteoinductive potential of demineralized freeze-dried bone allograft in human non-orthotopic sites: A pilot study. J Periodontol 2001;72:1064-1068.
3. Landi L, Pretel RW, Hakimi NM, Setayesh R. Maxillary sinus floor elevation using a combination of DFDBA and bovine-derived porous hydroxyapatite: A preliminary histologic and histomorphometric report. Int J Periodontics Restorative Dent 2000;20:574-583.
4. Wilkins RM, Kelly CM, Giusti DE. Bioassayed demineralized bone matrix and calcium sulfate: bone-grafting procedures. Ann Chir Gynecol 1999;88: 180-185.
5. Smiler DG. Comparison of anorganic bovine mineral with and without synthetic peptide in a sinus elevation: A case study. Implant Dent 2001;10:139-142.
6. Carinci F, Francioso F, Rubini C, et al. Genetic portrait of malignant granular cell odontogenic tumour. Oral Oncol 2003; 39:69-77.
7. Carinci F, Francioso F, Piattelli A, et al. Genetic expression profiling of six odontogenic tumors. J Dent Res 2003;82: 551-557.
8. Carinci F, Pezzetti F, Volinia S, et al. Zirconium oxide: Analysis of MG63 osteoblast-like cell response by means of a microarray technology. Biomaterials 2004;25:215-228.
9. Gurinsky BS, Mills MP, Mellonig JT. Clinical evaluation of demineralized freze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. J Periodontol 2004;75: 1309-1318.
10. Klepp M, Hinrichs JE, Easlund T, Schaffer EM. Histologic evaluation of demineralized freeze-dried bone allografts in barrier membrane covered periodontal fenestration wounds and ectopic sites in dogs. J Clin Periodontol 2004;31:534-544.
11. Aichelmann-Reidy ME, Heath CD, Reynolds MA. Clinical evaluation of calcium sulfate in combination with demineralized freeze-dried bone allograft for the treatment of human intraosseous defects. J Periodontol 2004;75:340-347.
12. Kimble KM, Eber RM, Soehren S, Shyr Y, Wang HL Treatment of gingival recession using a collagen membrane with or without the use of demineralized freeze-dried bone allograft for space maintenance. J Periodontol 2004;75:210-220.
13. Froum S, Cho SC, Rosenberg E, Rohrer M, Tarnow D. Histological comparison of healing extraction sockets implanted with bioactive glass or demineralized freeze-dried bone allograft: A pilot study. J Periodontol 2002;73:94-102.
14. Lamb JW, Greewell H, Drisko C, Henderson RD, Scheetz JP, Rebitski G. A comparison of porous and non-porous Teflon membranes plus demineralized freeze-dried bone allograft in the treatment of Class II buccal/lingual furcation defects: A clinical reentry study. J Periodontol 2001;72:1580-1587.
15. Nevins M, Camelo M, Nevins ML, Schenk RK, Lynch SE. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J Periodontol 2003;74:1282-1292.
16. Nomura T, Katz JL, Powers MP, Saito C. Evaluation of the micromechanical elastic properties of potential bone-grafting materials J Biomed Mater Res (in press).
17. Siegel JA, Burk CD, Parmiter AH, Emanuel BS. Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor. Genes Chromosomes Cancer 1992;5:104-108.
18. Biegel JA, Rorke LB, Packer RJ, Emanuel BS. Monosomy 22 in rhabdoid or atypical tumors of the brain. J Neurosurg 1990;73: 710-714.
19. Bonnin JM, Rubinstein LJ, Palmer NF, Beckwith JB. The association of embryonal tumors originating in the kidney and in the brain: A report of seven cases. Cancer 1984;54:2137-2146.
20. Burger PC, Yu IT, Tihan T, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: A pediatric oncology group study. Am J Surg Pathol 1998;22: 1083-1092.
21. Welsh GI, Kadereit S, Coccia EM, Hovanessian AG, Meurs EF. Colocalization within the nucleolus of two highly related IFN-induced human nuclear phosphoproteins with nucleolin. Exp Cell Res 1999; 250:62-74.
22. Qian Y-W, Lee EYHP. Dual retinoblastoma-binding proteins with properties related to a negative regulator of Ras in yeast. J Bio Chem 1995;270:25507- 25513.
23. Qian YW, Wang YCJ, Hollingsworth RE, Jones D, Ling N, Lee EYHP. A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature 1993;364: 648-652.
24. Fusco C, Reymond A, Zervos AS. Molecular cloning and characterization of a novel retinoblastoma-binding protein. Genomics 1998;51:351-358.
25. Li S, Ting NSY, Zheng L, et al. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 2000;406:210-215.
26. Zhou G, Bao ZQ, Dixon JE. Components of a new human protein kinase signal transduction pathway. J Biol Chem 1995;270: 12665-12669.
27. Joza N, Susin SA, Daugas E, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001;410:549-554.
28. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397:441-446.
29. Yu SW, Wang H, Poitras MF. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002;297:259-263.
30. Kremer EJ, Kalatzis V, Baker E, Callen DF, Sutherland GR, Maliszewski CR. The gene for the human IgA Fc receptor maps to 19q13.4. Hum Genet 1992;89:107-108.
31. Maliszewski CR, March CJ, Schoenborn MA, Gimpel S, Shen L. Expression cloning of a human Fc receptor for IgA. J Exp Med 1990;172:1665-1672.
32. Monteiro RC, Hostoffer RW, Cooper MD, Bonner JR, Gartland GL, Kubagawa H. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 1993;92:1681-1685.
33. Marita I, Goto S, Saito N, et al. Genetic polymorphisms in the promoter and 5-prime UTR region of the Fc alpha receptor (CD89) are not associated with a risk of IgA nephropathy. J Hum Genet 2001;46: 694-698.
34. Pleass RJ, Andrews PD, Kerr MA, Woof JM. Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils. Biochem J 1996;318: 771-777.
35. Shimokawa T, Tsuge T, Okumura K, Ra C. Identification and characterization of the promoter for the gene encoding the human myeloid IgA Fc receptor (Fc-alpha-R, CD89). Immunogenetics 2000;51: 945-954.
36. Tsuge T, Shimokawa T, Horikoshi S, Tomino Y, Ra C. Polymorphism in promoter region of Fc-alpha receptor gene in patients with IgA nephropathy. Hum Genet 2001;108: 128-133.
37. de Wit TP, Morton HC, Cape PJA, van de Winkel JGJ. Structure of the gene for the human myeloid IgA Fc receptor (CD89). J Immunol 1995;155:1203-1209.
38. Herr AB, Baluster ER, Bjorkman PJ. Insights into IgA-mediated immune responses from the crystal structures of human Fc-alpha-RI and its complex with IgAI-Fc. Nature 2003;423:614-620.
39. Crackower MA, Kolas NK, Noguchi J, et al. Essential role of Fkbp6 in male fertility and homologous chromosome pairing in meiosis. Science 2003;300:1291-1295.
40. Meng X, Lu X, Morris CA, Keating MT. A novel human gene FKBP6 is deleted in Williams syndrome. Genomics 1998;52: 130-137.
41. Watanabe H, Kimata K, Line S, et al. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat Genet 1994;7:154-157.
42. Just W, Klett C, Vetter U, Vogel W. Assignment of the human aggrecan gene AGC1 to 15q25-q26.2 by in situ hybridization. Hum Genet 1993;92:516-518.
43. Kimata K, Barrach HJ, Brown KS, Pennypacker JP. Absence of proteoglycan core protein in cartilage from the cmd/cmd (cartilage deficiency) mouse. J Biol Chem 1981;256:6961-6968.
44. Zhang W, Morris QD, Chang R, et al. The functional landscape of mouse gene expression J Biol 2004;3:21. Available at: http://Jbiol/com/content/3/5/21.
45. Clancy BM, Johnson JD, Lambert AJ, et al. A gene expression profile for endochondral bone formation: Oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps. Bone 2003;33:46-63.
46. Fyodorov D, Nelson T, Deneris E. Pet-1, a novel ETS domain factor that can activate neuronal nAchR gene transcription. J Neurobiol 1998;34:151-163.
47. Hendricks TJ, Fyodorov DV, Wegman U, et al. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behaviour. Neuron 2003;37:233-247.
48. Peter M, Couturier J, Pacquement H, et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 1997;14: 1159-1164.
49. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. cDNAcloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 1996; 271:29265-29270.
50. Guo J, Apiou F, Mellerin MP, Lebeau B, Jacques Y, Minvielle S. Chromosome mapping and expression of the human interleukin-13 receptor. Genomics 1997;42: 141-145.
51. Heinzmann H, Mao XQ, Akaiwa M, et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Molec Genet 2000;9:549-559.
52. Youssoufian H, McAfee M, Kwiatkowski DJ. Cloning and chromosomal localization of the human cytoskeletal alpha-actinin gene reveals linkage to the beta-spectrin gene. Am J Hum Genet 1990;47:62-72.
53. Chavanas S, Gache Y, Tadini G, et al. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophie benign epidermolysisbullosa. J Invest Derm 1997;109:74-77.
54. Copeland NG, Gilbert DJ, Li K, et al. Chromosomal localization of mouse bullous pemphigoid antigens, BPAG1 and BPAG2: Identification of a new region of homology between mouse and human chromosomes. Genomics 1993;15:180-181.
55. Darling TN, Koh BB, Bale SJ, et al. A deletion mutation in COLI7A1 in five Austrian families with generalized atrophic benign epidermolysis bullosa represents propagation of an ancestral allele. J Invest Derm 1998;110:170-173.
56. Darling TN, Yee C, Bauer JW, Hintner H, Yancey KB. Revertant mosaicism: Partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation. J Clin Invest 1999;103:1371-1377.
57. Darling TN, Yee C, Koh B, et al. Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa. J Invest Derm 1998; 110:165-169.